A
$ Value
$0
Shares
55,000
Price
$0
Filed
Feb 25
Insider
Name
Kalofonos Isabel
Title
Chief Commercial Officer
CIK
0001975163
Roles
Officer
Transaction Details
Transaction Date
2026-02-23
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
55,000
Footnotes
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 1, 2027. | The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 23, 2026.
Filing Info
Kalofonos Isabel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-23 | CRNX | A | $0 |
| 2026-02-23 | CRNX | A | $0 |
| 2026-01-05 | CRNX | M | $101K |
| 2026-01-05 | CRNX | ▼ | $138K |
| 2026-01-05 | CRNX | M | $0 |
Other Insiders at CRNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Vivaldi Coelho Rogerio | — | $181K | 2026-03-12 |
|
Schilke Tobin
Chief Financial Officer
|
— | $266K | 2026-03-03 |
| Okey Stephanie | — | $119K | 2026-03-03 |
|
Struthers Richard Scott
President & CEO
|
— | $822K | 2026-03-16 |
|
Knight Jeff E.
Chief Dev. & Operating Officer
|
— | $3.4M | 2026-04-08 |
|
Knight Jeff E.
Chief Operating Officer
|
— | $370K | 2026-03-16 |
|
Betz Stephen F.
Chief Scientific Officer
|
— | $397K | 2026-03-16 |
|
Kalofonos Isabel
Chief Commercial Officer
|
— | — | 2026-02-23 |